PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity

Viruses. 2020 Dec 30;13(1):46. doi: 10.3390/v13010046.

Abstract

P-selectin glycoprotein ligand-1 (PSGL-1) is a cell surface glycoprotein that binds to P-, E-, and L-selectins to mediate the tethering and rolling of immune cells on the surface of the endothelium for cell migration into inflamed tissues. PSGL-1 has been identified as an interferon-γ (INF-γ)-regulated factor that restricts HIV-1 infectivity, and has recently been found to possess broad-spectrum antiviral activities. Here we report that the expression of PSGL-1 in virus-producing cells impairs the incorporation of SARS-CoV and SARS-CoV-2 spike (S) glycoproteins into pseudovirions and blocks pseudovirus attachment and infection of target cells. These findings suggest that PSGL-1 may potentially inhibit coronavirus replication in PSGL-1+ cells.

Keywords: cellular antiviral factor; coronavirus; pseudovirion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • COVID-19 / virology*
  • Cell Line
  • HEK293 Cells
  • HIV-1 / drug effects
  • Humans
  • Interferon-gamma
  • Membrane Glycoproteins / antagonists & inhibitors*
  • Membrane Glycoproteins / metabolism*
  • SARS-CoV-2 / drug effects*
  • Spike Glycoprotein, Coronavirus / drug effects*
  • Virion*
  • Virus Attachment / drug effects
  • Virus Internalization / drug effects

Substances

  • Membrane Glycoproteins
  • P-selectin ligand protein
  • Spike Glycoprotein, Coronavirus
  • spike glycoprotein, SARS-CoV
  • Interferon-gamma